Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)
|
March 6, 2018
Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus
Rachel J Fenske, Michelle E Kimple
Nutrition and Healthy Aging
|
April 28, 2017
Dietary polyunsaturated fatty acids and their metabolites: Implications for diabetes pathophysiology, prevention, and treatment
Joshua C Neuman, Rachel J Fenske, Michelle E Kimple
American Journal of Physiology. Endocrinology and Metabolism
|
July 7, 2021
Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance
Jaclyn A Wisinski, Austin Reuter, Darby C Peter, et al.
Iscience
|
July 14, 2020
Differential Expression of Ormdl Genes in the Islets of Mice and Humans with Obesity
Hugo Lee, Rachel J Fenske, Tugce Akcan, et al.
Annals of Clinical and Translational Neurology
|
October 6, 2021
Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome
Santhi N Logel, Ellen L Connor, David A Hsu, et al.
Journal of the Endocrine Society
|
June 4, 2024
Gα<sub>z</sub>-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice
Rachel J Fenske, Haley N Wienkes, Darby C Peter, et al.
The American Journal of Clinical Nutrition
|
March 9, 2026
Estimating proton density fat fraction using computed tomography attenuation in skeletal muscle and adipose tissue in a prospective clinical cohort
Rachel J Fenske, Jevin Lortie, Luke M Vander Kooy, et al.
Molecular Endocrinology (Baltimore, Md.)
|
April 7, 2016
Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes
Allison L Brill, Jaclyn A Wisinski, Mark T Cadena, et al.
Metabolites
|
December 23, 2022
Plasma Prostaglandin E<sub>2</sub> Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation
Rachel J Fenske, Alicia M Weeks, Michael Daniels, et al.
Pharmacology Research & Perspectives
|
March 11, 2021
Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion
Harpreet K Sandhu, Joshua C Neuman, Michael D Schaid, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Experimental Biology and Medicine (Maywood, N.J.)
|
March 6, 2018
Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus
Rachel J Fenske, Michelle E Kimple
Nutrition and Healthy Aging
|
April 28, 2017
Dietary polyunsaturated fatty acids and their metabolites: Implications for diabetes pathophysiology, prevention, and treatment
Joshua C Neuman, Rachel J Fenske, Michelle E Kimple
American Journal of Physiology. Endocrinology and Metabolism
|
July 7, 2021
Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance
Jaclyn A Wisinski, Austin Reuter, Darby C Peter, et al.
Iscience
|
July 14, 2020
Differential Expression of Ormdl Genes in the Islets of Mice and Humans with Obesity
Hugo Lee, Rachel J Fenske, Tugce Akcan, et al.
Annals of Clinical and Translational Neurology
|
October 6, 2021
Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome
Santhi N Logel, Ellen L Connor, David A Hsu, et al.
Journal of the Endocrine Society
|
June 4, 2024
Gα<sub>z</sub>-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice
Rachel J Fenske, Haley N Wienkes, Darby C Peter, et al.
The American Journal of Clinical Nutrition
|
March 9, 2026
Estimating proton density fat fraction using computed tomography attenuation in skeletal muscle and adipose tissue in a prospective clinical cohort
Rachel J Fenske, Jevin Lortie, Luke M Vander Kooy, et al.
Molecular Endocrinology (Baltimore, Md.)
|
April 7, 2016
Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes
Allison L Brill, Jaclyn A Wisinski, Mark T Cadena, et al.
Metabolites
|
December 23, 2022
Plasma Prostaglandin E<sub>2</sub> Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation
Rachel J Fenske, Alicia M Weeks, Michael Daniels, et al.
Pharmacology Research & Perspectives
|
March 11, 2021
Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion
Harpreet K Sandhu, Joshua C Neuman, Michael D Schaid, et al.
Page
of 3